Metraipolis › archive › dc_051933b5ee5e

From metabolic to pathologic complete response: case report of Neoadjuvant Lorlatinib in Stage IIIB ALK-positive NSCLC combined with uniportal VATS — Europe PMC PMID:42366402

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42366402
DOI
10.1186/s13019-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-18T15:42:44.318Z
SHA-256 of the archived text
0a3d4fd8b43db81dca0b0c4ac8ed8906a3d410d5af4486f3e855c4869040e9f1
Stable URL of this page
https://metraipolis.com/documento/dc_051933b5ee5e

How to cite

From metabolic to pathologic complete response: case report of Neoadjuvant Lorlatinib in Stage IIIB ALK-positive NSCLC combined with uniportal VATS — Europe PMC PMID:42366402 — Europe PMC (en), https://europepmc.org/article/MED/42366402 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_051933b5ee5e (Metraipolis archive dc_051933b5ee5e, sha256 0a3d4fd8b43db81dca0b0c4ac8ed8906a3d410d5af4486f3e855c4869040e9f1)
BibTeX
@misc{dc051933b5ee5e,
  title = {From metabolic to pathologic complete response: case report of Neoadjuvant Lorlatinib in Stage IIIB ALK-positive NSCLC combined with uniportal VATS — Europe PMC PMID:42366402},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42366402},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_051933b5ee5e; sha256 0a3d4fd8b43db81dca0b0c4ac8ed8906a3d410d5af4486f3e855c4869040e9f1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42366402. Agents can read the archived copy with the MCP tool read_document.